Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NovaDerme is a French biotechnology company specializing in tissue engineering and the development of advanced 3D skin models. The company focuses on creating reconstructed human skin equivalents that serve as predictive tools for pharmacological testing, cosmetic evaluation, and clinical research. By utilizing primary human cells, NovaDerme produces models that closely mimic the physiological properties of native skin, including the dermis and epidermis. Their services support the pharmaceutical and dermo-cosmetic industries in assessing product efficacy and safety without the need for animal testing. Additionally, the company is involved in research regarding regenerative medicine and wound healing applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novaderme.